This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Toxic effect of organic solvents
ST19_TOXIC_EFFECT_ORGANIC_SOLVE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
145 |
4. Check minimum number of eventsNone |
145 |
5. Include endpointsNone |
145 |
6. Filter based on genotype QC (FinnGen only) |
145 |
Control definitions (FinnGen only)
- Control exclude
- ST19_TOXIC_EFFEC_SUBST_CHIEF_NONME_SOURCE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- T5[1-9]|T6[0-5]
- Name in latin
- Effectus toxicus solventium organicorum
Similar endpoints
↥List of similar endpoints to
Toxic effect of organic solvents
based on the number of shared cases.
Similar with more cases:
- Toxic effects of substances chiefly nonmedicinal as to source
- Injury, poisoning and certain other consequences of external causes
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 145 | 51 | 94 |
| Unadjusted period prevalence (%) | 0.03 | 0.02 | 0.04 |
| Median age at first event (years) | 36.52 | 23.30 | 43.69 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 131
- Matched controls
- 1309
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T52.9
ICD-10 Finland
Toxic effect: Organic solvent, unspecified
+∞
82.1
70
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
46.2
47.5
58
22
T36
ICD-10 Finland
Poisoning by systemic antibiotics
31.6
42.1
57
31
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
17.9
27.8
45
37
T52.8
ICD-10 Finland
Toxic effect: Other organic solvents
+∞
21.4
20
*
T52.0
ICD-10 Finland
Toxic effect: Petroleum products
+∞
20.3
19
*
T52.3
ICD-10 Finland
Toxic effect: Glycols
+∞
18.1
17
*
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
26.3
17.6
24
11
WX892
NOMESCO Finland
Monitored bed care
12.0
16.6
31
33
Z72.2
ICD-10 Finland
Drug use
55.0
16.5
19
*
N07BB01
ATC
disulfiram; oral
16.7
16.4
26
19
N05AH04
ATC
quetiapine; oral
5.6
15.2
52
138
X46
ICD-10 Finland
Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours
+∞
14.9
14
*
X57
ICD-10 Finland
Unspecified privation
18.9
14.0
21
13
T40.9
ICD-10 Finland
Poisoning: Other and unspecified psychodysleptics [hallucinogens]
155.4
13.7
14
*
N05BA01
ATC
diazepam; systemic, rectal
7.1
13.5
35
64
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
+∞
12.7
12
*
N05AH03
ATC
olanzapine; systemic
8.0
12.5
29
45
F32.9
ICD-10 Finland
Depressive episode, unspecified
5.7
12.5
39
91
P15
ICPC
Chronic alcohol abuse
15.5
12.4
20
15
P19
ICPC
Drug abuse
24.1
12.4
17
8
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
+∞
11.6
11
*
F10.20
ICD-10 Finland
Alcohol dependence currently independent
15.8
11.4
18
13
N06AX11
ATC
mirtazapine; oral
3.9
11.3
58
220
N06AB04
ATC
citalopram; systemic
4.6
11.3
44
129
T74.1
ICD-10 Finland
Physical abuse
18.0
10.7
16
10
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.8
10.6
38
102
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
119.2
10.6
11
*
T51.0
ICD-10 Finland
Toxic effect: Ethanol
+∞
10.6
10
*
N05CD07
ATC
temazepam; oral
6.7
10.4
27
49
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
13.7
10.2
17
14
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
28.6
10.0
13
5
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
15.0
10.0
16
12
P29
ICPC
Psychological sympt/compl other
7.5
9.8
23
36
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
59.5
9.8
11
*
WX730
NOMESCO Finland
Conventional respirator
16.7
9.8
15
10
F29
ICD-10 Finland
Unspecified nonorganic psychosis
8.4
9.7
21
29
B18.2
ICD-10 Finland
Chronic viral hepatitis C
13.8
9.7
16
13
N05BA12
ATC
alprazolam; oral
5.8
9.6
28
59
N05AX08
ATC
risperidone; systemic
6.2
9.6
26
50
N05AA02
ATC
levomepromazine; systemic
8.9
9.6
20
26
F10.24
ICD-10 Finland
Alcohol depence active use
23.8
9.6
13
6
T40.6
ICD-10 Finland
Poisoning: Other and unspecified narcotics
107.5
9.5
10
*
N05BA04
ATC
oxazepam; oral
3.8
9.5
48
174
N03AG01
ATC
valproic acid; systemic, rectal
6.6
9.3
24
43
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
5.9
9.2
26
53
P16
ICPC
Acute alcohol abuse
20.4
9.1
13
7
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
26.2
9.1
12
5
Z2446
NOMESCO Finland
Social worker
5.6
8.9
26
55
N03AE01
ATC
clonazepam; systemic
8.4
8.8
19
26
TKC20
NOMESCO Finland
Catheterisation of bladder
6.6
8.6
22
39
X45
ICD-10 Finland
Accidental poisoning by and exposure to alcohol
+∞
8.4
8
*
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
15.9
8.4
13
9
N05CF01
ATC
zopiclone; oral
3.3
8.1
49
200
X59
ICD-10 Finland
Exposure to unspecified factor
3.5
8.0
43
162
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
8.3
8.0
17
23
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
9.8
7.8
15
17
N05AX12
ATC
aripiprazole; systemic
7.3
7.7
18
28
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
26.8
7.7
10
*
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
26.8
7.7
10
*
S01.0
ICD-10 Finland
Open wound of scalp
5.9
7.7
21
41
N05AN01
ATC
lithium; oral
11.0
7.2
13
13
F10.25
ICD-10 Finland
Alcohol dependence continuous use
11.0
7.2
13
13
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
6.3
7.1
18
32
SPAT1240
SPAT
Therapeutic discussion
4.2
7.1
27
76
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
7.9
6.9
15
21
F19.30
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated
42.3
6.8
8
*
ZY000
NOMESCO Finland
Hospital inpatient
15.3
6.5
10
7
F15.0
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, acute intoxication
73.3
6.5
7
*
F19.59
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS
73.3
6.5
7
*
ZXY60
NOMESCO Finland
2-person team, nurses
73.3
6.5
7
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
5.6
6.5
18
36
N05CF02
ATC
zolpidem; oral
3.6
6.5
30
100
V03AA01
ATC
NA
19.2
6.4
9
5
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
28.2
6.3
8
*
T52.2
ICD-10 Finland
Toxic effect: Homologues of benzene
+∞
6.3
6
*
XF400
NOMESCO Finland
ECG with 12 standard connections
3.5
6.2
30
103
N05BA06
ATC
lorazepam; systemic, sublingual
7.3
6.2
14
21
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
13.4
6.2
10
8
F31.8
ICD-10 Finland
Other bipolar affective disorders
10.8
6.2
11
11
N05AB03
ATC
perphenazine; systemic, rectal
7.9
6.1
13
18
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028707) Methadone [Presence] in Urine by Screen method
34
43
10.02
26.31
4.0
2.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
39
77
6.56
20.16
3.9
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
39
92
5.43
16.48
6.1
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
40
98
5.26
16.17
6.2
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
40
99
5.20
15.97
6.0
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
32
65
6.03
15.86
7.6
1.8
—
—
—
0
0
(4198724)
21
9
27.00
15.62
1.8
3.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
16
14
12.72
15.58
2.0
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
39
98
5.08
15.25
6.1
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
38
97
4.95
14.53
5.9
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
52
204
3.42
10.67
2.9
2.1
%
1.6
1.3
2.70
47
185
(3000991) Gas panel - Venous blood
30
88
4.04
9.38
9.5
10.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
60
274
3.03
9.35
9.2
4.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
30
90
3.94
9.08
6.3
3.3
—
—
—
0
0
(3012544) pH of Venous blood
30
93
3.81
8.65
4.2
4.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
28
92
3.53
7.37
4.4
4.2
mmol/l
2.4
1.8
0.30
21
70
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
75
424
2.59
7.35
7.8
7.3
mmol/l
1.2
1.2
0.80
70
389
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
7
0
+∞
7.35
3.3
0.0
mmol/l
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
7
0
+∞
7.35
3.3
0.0
mmol/l
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
78
460
2.51
6.86
8.1
7.8
mmol/l
1.2
1.2
0.50
69
397
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
39
171
2.75
6.24
3.2
3.2
ng/l
715.6
246.0
0.32
19
120
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
67
381
2.41
6.23
4.2
3.2
u/l
45.3
30.4
1.77
62
367
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
21
65
3.61
6.00
8.0
8.3
mmol/l
22.2
24.7
1.85
21
65
(3019150) Specific gravity of Urine by Refractometry
51
260
2.48
5.99
6.0
3.1
kg/l
1.0
1.0
—
9
25
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
20
61
3.64
5.83
1.3
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
32
131
2.85
5.79
1.3
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
63
363
2.30
5.54
2.4
2.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
84
552
2.24
5.31
7.5
6.6
umol/l
9.8
11.4
1.31
76
523
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
33
146
2.63
5.12
2.5
2.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
23
5.09
5.10
3.1
3.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
9
9
10.56
5.10
3.6
1.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
16
47
3.70
4.91
14.3
21.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
25
99
2.84
4.77
2.2
1.8
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
24
93
2.89
4.76
11.1
15.4
g/l
122.3
123.7
0.17
24
88
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
19
64
3.27
4.76
1.5
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
41
209
2.34
4.69
1.7
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
49
273
2.20
4.52
11.9
7.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
91
644
2.11
4.46
7.4
5.5
mmol/l
6.5
6.6
0.11
84
590
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
24
97
2.77
4.41
2.2
1.7
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
24
99
2.71
4.24
11.2
14.6
%
96.2
95.8
0.15
24
93
(3018418) pH of Serum or Plasma
45
258
2.08
3.78
3.4
3.4
ph
7.4
7.4
—
8
48
(3052851) Hemolysis interference index of Serum or Plasma
11
30
3.89
3.71
3.7
3.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
30
147
2.31
3.70
2.5
2.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
58
369
1.95
3.62
6.5
5.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
13
6.44
3.55
1.3
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
47
280
2.00
3.53
2.5
2.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
31
159
2.21
3.43
2.5
2.5
e6/l
0.8
0.9
0.17
14
99
(3044640) Blood type and Crossmatch panel - Blood
52
329
1.91
3.24
3.6
2.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
106
841
1.97
3.24
10.3
7.2
u/l
79.1
76.5
0.47
100
785
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
30
157
2.15
3.15
2.4
2.8
e6/l
3.6
3.0
0.11
12
98
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
16
5.22
3.09
1.8
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
29
152
2.13
3.03
1.6
1.6
nmol/l
964.4
1173.1
0.50
22
120
(3018095) Leukocytes [#/volume] in Urine
56
370
1.84
3.02
2.8
3.4
e6/l
36.3
134.6
1.07
35
276
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
55
362
1.84
3.00
2.3
1.8
pmol/l
93.7
92.4
0.09
36
211
(3044290) Cell count panel - Cerebral spinal fluid
8
17
4.91
2.96
2.3
1.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
104
833
1.88
2.92
4.3
3.5
pmol/l
14.1
14.7
2.01
95
756
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
26
133
2.16
2.88
1.5
3.5
umol/l
3.8
6.8
1.86
17
108
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
9
23
4.10
2.82
1.3
1.3
mg/l
485.6
634.3
—
9
23
(3007853) Bacteria identified in Skin by Aerobe culture
25
127
2.17
2.81
1.6
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
8
19
4.39
2.72
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
8
19
4.39
2.72
1.4
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
13
49
2.82
2.70
1.8
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
56
383
1.75
2.63
4.4
3.5
ng/l
27.2
29.6
0.10
33
227
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
8
20
4.17
2.61
1.3
1.3
mmol/l
3.3
3.8
—
8
20
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
44
282
1.80
2.56
1.8
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
44
283
1.80
2.53
2.7
2.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
26
3.62
2.53
1.2
1.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
48
317
1.77
2.52
2.5
2.8
e6/l
10.9
257.9
0.71
34
262
(3030467) Casts [#/volume] in Urine by Automated count
44
284
1.79
2.50
2.6
2.7
e6/l
0.4
0.4
0.06
29
230
(3026782) Osmolality of Urine
36
221
1.84
2.39
1.8
2.6
mosm/kgh2o
547.1
588.5
0.48
31
191
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
40
256
1.78
2.32
2.4
2.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
9
5.71
2.23
1.0
1.4
mmol/l
2.4
2.1
—
5
9
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
9
5.71
2.23
1.0
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
16
75
2.27
2.18
2.2
2.7
e9/l
61.9
71.6
—
7
63
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
6
14
4.42
2.17
18.5
9.0
mmol/l
0.6
0.6
—
6
14
(3013115) Eosinophils [#/volume] in Blood
78
609
1.61
2.09
10.0
6.6
e9/l
0.2
0.2
0.12
66
556
(3016018) Differential panel - Cerebral spinal fluid
5
10
5.13
2.09
1.2
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
118
1025
1.81
2.06
5.4
4.0
mu/l
1.8
1.8
0.16
108
941
(3006504) Eosinophils/100 leukocytes in Blood
72
554
1.60
2.03
7.9
6.1
%
2.5
2.7
0.58
64
530
(3019069) Monocytes/100 leukocytes in Blood
72
555
1.59
2.01
8.1
6.4
%
8.2
8.6
0.44
64
536
(3032080) INR in Blood by Coagulation assay
52
371
1.63
2.00
11.4
7.4
inr
1.2
1.2
0.02
17
121
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
123
1086
1.87
1.98
16.6
10.8
ml/min/173m2
96.4
90.4
1.94
97
872
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
9
33
2.84
1.97
1.4
2.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
75
586
1.58
1.96
8.7
6.0
e9/l
0.6
0.6
0.59
63
525
(3028271) Lactate [Moles/volume] in Capillary blood
6
16
3.86
1.95
4.0
2.0
mmol/l
1.8
1.6
—
6
16
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
37
243
1.70
1.94
3.8
2.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
85
686
1.58
1.92
15.7
9.6
e9/l
4.5
4.1
0.63
69
611
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
28
2.96
1.89
1.0
1.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
75
593
1.55
1.82
8.8
6.0
e9/l
0.0
0.0
0.92
62
533
(3022096) Basophils/100 leukocytes in Blood
69
538
1.54
1.77
8.1
6.2
%
0.6
0.7
0.09
61
514
(3021589) Normoblasts [#/volume] in Blood
66
511
1.54
1.74
10.1
9.0
e9/l
0.0
0.0
0.53
50
412
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
46
0.00
1.74
0.0
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
13
3.94
1.73
3.0
2.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
14
3.66
1.63
4.0
3.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
10
201
0.46
1.59
1.6
1.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
72
578
1.49
1.56
8.2
6.1
%
25.9
28.8
1.32
64
556
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
50
374
1.51
1.51
2.7
2.9
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
17
95
1.89
1.50
4.1
6.6
mmol/l
6.5
7.8
0.54
17
90
(3019225) pH of Specimen
16
89
1.90
1.44
3.4
3.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
128
1173
1.78
1.42
22.7
12.3
mg/l
27.8
23.6
0.64
105
913
(3019198) Lymphocytes [#/volume] in Blood
75
616
1.45
1.40
8.9
6.1
e9/l
1.9
2.0
0.32
62
562
(40768797) Stomach Pathology biopsy report
21
129
1.73
1.39
1.1
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
37
264
1.54
1.38
3.2
3.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
17
3.01
1.37
3.2
1.8
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
17
3.01
1.37
3.2
1.6
%
69.4
63.9
—
5
17
(3034770) Mitochondria Ab [Titer] in Serum
0
37
0.00
1.36
0.0
1.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
37
0.00
1.36
0.0
1.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
70
570
1.44
1.35
8.1
5.9
%
58.0
56.9
0.28
63
546
(4010399)
14
76
1.93
1.35
1.4
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
34
241
1.54
1.30
3.3
3.6
ng/l
1512.0
1062.9
0.33
26
191
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
33
234
1.53
1.26
1.6
1.8
mg/l
0.8
1.2
0.68
22
174
(3002256) Pathology report gross observation
19
119
1.69
1.19
1.1
1.3
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
5
20
2.55
1.16
7.2
2.4
kpa
5.1
4.9
—
5
20
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
20
2.55
1.16
1.2
1.8
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
5
20
2.55
1.16
7.2
2.5
kpa
9.9
9.2
—
5
20
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
40
2.06
1.14
1.3
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
120
1100
1.53
1.11
4.8
3.7
mmol/l
6.2
5.8
0.58
107
1010
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
11
59
1.94
1.10
2.5
4.4
pmol/l
4.7
4.7
0.05
11
50
(3000494) Fungus identified in Specimen by Culture
19
122
1.64
1.09
1.4
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
37
277
1.45
1.09
2.2
2.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
9
46
2.02
1.06
2.7
1.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
9
47
1.97
1.04
4.3
3.0
%
0.6
0.7
—
9
47
(1761482) Bacteria [#/volume] in Urine by Culture
0
32
0.00
0.96
0.0
3.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
79
1.71
0.91
1.1
1.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
89
788
1.34
0.90
3.2
3.6
mm/h
10.8
9.3
0.61
80
730
(3037467) Urinalysis macro (dipstick) panel - Urine
87
768
1.33
0.90
3.9
3.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
42
1.96
0.90
1.8
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
11
64
1.78
0.89
1.4
1.4
—
16.3
—
0
6
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
30
2.04
0.88
1.3
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
36
453
0.73
0.88
1.9
2.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
6
31
1.97
0.85
1.7
1.9
%
159.3
185.7
—
6
31
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
32
1.91
0.82
1.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
0
28
0.00
0.77
0.0
3.0
—
92.6
—
0
21
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
54
1.71
0.76
1.7
2.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
5
24
2.12
0.75
1.4
1.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
9
56
1.65
0.74
2.4
3.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
16
111
1.50
0.69
3.2
4.1
%
32.3
29.8
0.34
11
78
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
27
1.88
0.69
1.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
19
137
1.45
0.69
2.0
2.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
12
78
1.59
0.68
2.0
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
14
198
0.68
0.66
1.2
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
10
152
0.63
0.65
1.4
1.6
—
—
—
0
0
(3013512) EKG study
33
265
1.32
0.64
3.7
3.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
9
137
0.63
0.64
1.2
1.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
88
956
0.80
0.62
3.7
3.5
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
0
20
0.00
0.61
0.0
2.5
—
7.2
—
0
20
(3008037) Lactate [Moles/volume] in Venous blood
0
21
0.00
0.60
0.0
2.4
—
1.5
—
0
21
(3045424) Erythrocytes [Presence] in Urine
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
32
259
1.30
0.59
2.6
2.5
umol/l
344.2
6854.7
1.07
27
225
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
21
271
0.74
0.59
3.0
2.9
ug/l
0.5
0.7
0.60
16
167
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
23
0.00
0.59
0.0
1.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
23
0.00
0.59
0.0
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
11
73
1.55
0.58
2.2
2.3
—
16.7
—
0
6
(3019060) Gas panel - Arterial blood
11
73
1.55
0.58
7.4
11.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
10
65
1.58
0.57
10.0
15.5
mmol/l
26.9
24.0
—
10
59
(3035350) Ketones [Presence] in Urine by Test strip
64
569
1.22
0.54
3.5
3.1
estimate
0.0
0.0
0.00
13
119
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
109
1024
1.26
0.54
4.7
4.7
mmol/mol
37.8
39.1
0.84
102
967
(4034850)
6
39
1.56
0.53
15.8
11.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
9
63
1.46
0.53
1.7
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
46
396
1.24
0.52
2.0
1.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
40
1.52
0.52
2.0
2.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
36
305
1.24
0.47
1.2
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
11
79
1.42
0.42
2.0
3.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
0
15
0.00
0.41
0.0
1.5
—
1.1
—
0
7
(21494815) CD4 cells/100 lymphocytes in Specimen
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
0
15
0.00
0.41
0.0
1.6
—
7582.7
—
0
9
(3023420) DNA double strand Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.5
—
15.0
—
0
16
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
16
0.00
0.41
0.0
2.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
10
137
0.71
0.41
1.2
1.5
—
429.1
—
0
22
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
102
0.67
0.41
1.4
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
17
0.00
0.41
0.0
2.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
34
1.49
0.41
1.4
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
34
1.49
0.41
1.6
1.8
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
18
0.00
0.40
0.0
2.2
—
13.1
—
0
18
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
35
1.44
0.39
1.2
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
26
218
1.23
0.37
1.8
1.9
—
—
—
0
0
(3044889) 12 lead EKG panel
79
735
1.16
0.36
4.9
3.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
41
1.48
0.36
3.7
2.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
24
282
0.82
0.33
4.7
4.9
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
62
570
1.15
0.33
4.2
4.3
estimate
0.0
0.0
0.00
13
120
(3029937) Albumin [Presence] in Urine by Test strip
36
317
1.18
0.32
4.1
3.4
estimate
0.0
0.0
0.00
11
114
(3007164) IgA [Mass/volume] in Serum or Plasma
23
267
0.84
0.29
1.3
1.5
g/l
2.3
2.4
0.29
16
173
(3022621) pH of Urine by Test strip
5
72
0.68
0.27
6.0
2.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
62
577
1.13
0.26
3.5
3.2
estimate
0.0
0.0
0.00
12
111
(3012516) Albumin [Mass/volume] in Urine
28
246
1.17
0.26
1.9
3.0
mg/l
13.0
68.3
3.15
18
162
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
54
500
1.13
0.25
5.7
4.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
11
0.00
0.21
0.0
5.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
9.5
—
0
10
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.0
—
902.8
—
0
10
(3004616) Nuclear Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(44813793)
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
48
1.26
0.20
1.0
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
14
0.00
0.20
0.0
1.9
—
535.8
—
0
6
(3009542) Hematocrit [Volume Fraction] of Blood
118
1150
1.14
0.20
24.9
12.5
%
40.3
41.3
0.82
92
947
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
14
118
1.21
0.20
1.6
2.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
10
120
0.82
0.17
1.8
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
18
159
1.15
0.16
1.3
1.2
iu/ml
36.7
37.4
—
5
41
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
80
0.74
0.16
1.5
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
38
357
1.09
0.13
4.6
4.0
%
20.0
20.0
0.00
20
148
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
47
447
1.08
0.12
3.7
3.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
115
1131
1.08
0.10
3.9
3.7
mmol/l
1.3
1.4
0.44
107
1056
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
5
45
1.11
0.10
4.6
4.2
%
63.2
52.8
—
5
45
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
46
1.09
0.09
1.6
2.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
28
298
0.93
0.09
1.3
1.3
u/ml
0.8
1.3
—
8
82
(40768443) Skin Pathology biopsy report
5
47
1.07
0.09
1.2
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
110
1082
1.07
0.09
3.7
3.4
mmol/l
1.5
1.3
1.10
102
1011
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
65
1.08
0.08
1.0
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
13
143
0.90
0.07
1.8
1.4
—
—
—
0
0
(4035726)
8
78
1.03
0.07
2.0
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
115
1136
1.06
0.06
4.1
3.7
mmol/l
4.7
4.6
0.35
108
1064
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
116
1147
1.06
0.05
4.5
4.0
mmol/l
2.9
2.8
0.41
106
1070
(3000492) Spirometry study
14
131
1.08
0.03
1.1
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
31
320
0.96
0.03
2.8
2.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
125
1241
1.05
0.03
19.5
11.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
27
262
1.04
0.02
2.5
3.8
mg/mmol
1.2
10.9
2.97
18
173
(36660697) Celiac disease serology panel - Serum
11
117
0.94
0.02
1.0
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
10
99
1.01
0.00
3.2
3.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
35
349
1.00
0.00
1.6
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
12
115
1.05
0.00
14.4
8.1
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
11.1
—
0
6
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(1002224) Polysomnography panel
5
56
0.89
0.00
1.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
6
0.00
0.00
0.0
1.8
—
1799.2
—
0
6
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
68
0.88
0.00
1.0
1.5
—
—
—
0
0
(4146454)
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(4024509)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
6
0.00
0.00
0.0
1.7
—
1.3
—
0
6
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
0
7
0.00
0.00
0.0
1.1
—
21.7
—
0
7
(3044242) Glucose [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
9
0.00
0.00
0.0
2.7
—
4.0
—
0
9
(3044927) Protein electrophoresis panel - Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
0
5
0.00
0.00
0.0
58.4
—
90.2
—
0
5
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
6
67
0.89
0.00
1.0
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
5
0.00
0.00
0.0
2.0
—
58.8
—
0
5
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
105.9
—
0
7
(3038026) Centromere Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
1.1
—
0
9
(3035285) Chloride [Moles/volume] in Venous blood
0
9
0.00
0.00
0.0
2.7
—
106.1
—
0
9
(3020891) Body temperature
5
50
1.00
0.00
6.4
6.0
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
0.4
—
0
5
(3041806) Other cells [#/volume] in Blood by Manual count
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
17.6
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_TOXIC_EFFECT_ORGANIC_SOLVE – Toxic effect of organic solvents
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).